tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Study finds GLP-1s may have link to eye disease, STAT reports
The FlyStudy finds GLP-1s may have link to eye disease, STAT reports
1d ago
AZN
LLY
Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says
PremiumThe Fly
Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says
2d ago
AZN
BMY
Blueprint Medicines price target raised to $129 from $102 at Morgan Stanley
PremiumThe Fly
Blueprint Medicines price target raised to $129 from $102 at Morgan Stanley
2d ago
SNY
BPMC
Sanofi’s Strategic Acquisition of Blueprint Medicines: A Boost to Rare Disease Portfolio and Long-term Growth
PremiumRatings
Sanofi’s Strategic Acquisition of Blueprint Medicines: A Boost to Rare Disease Portfolio and Long-term Growth
3d ago
SNY
Apple downgraded, Snowflake upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple downgraded, Snowflake upgraded: Wall Street’s top analyst calls
3d ago
DG
IP
Reddit initiated, Pinterest upgraded: Wall Street’s top analyst calls
PremiumThe FlyReddit initiated, Pinterest upgraded: Wall Street’s top analyst calls
4d ago
AAP
CAH
Sanofi announces new data from two clinical studies on Sarclisa
Premium
The Fly
Sanofi announces new data from two clinical studies on Sarclisa
4d ago
SNY
Sanofi price target raised to EUR 110 from EUR 108 at Guggenheim
Premium
The Fly
Sanofi price target raised to EUR 110 from EUR 108 at Guggenheim
4d ago
SNY
Sanofi price target lowered to EUR 118 from EUR 120 at Berenberg
PremiumThe Fly
Sanofi price target lowered to EUR 118 from EUR 120 at Berenberg
5d ago
SNY
Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
PremiumThe Fly
Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
5d ago
SNY
KYMR
Sanofi price target lowered to EUR 108 from EUR 121 at Guggenheim
PremiumThe Fly
Sanofi price target lowered to EUR 108 from EUR 121 at Guggenheim
5d ago
SNY
REGN
Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
PremiumThe Fly
Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
5d ago
X
BA
Sanofi acquisition of Blueprint Medicines ‘sensible,’ says BofA
PremiumThe FlySanofi acquisition of Blueprint Medicines ‘sensible,’ says BofA
5d ago
SNY
BPMC
Sanofi exercises license extension option to Nurix’s STAT6 program
Premium
The Fly
Sanofi exercises license extension option to Nurix’s STAT6 program
5d ago
SNY
NRIX
Sanofi resumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Sanofi resumed with an Equal Weight at Morgan Stanley
6d ago
SNY
Sanofi to acquire Blueprint Medicines for $129 per share in cash
PremiumThe Fly
Sanofi to acquire Blueprint Medicines for $129 per share in cash
6d ago
SNY
BPMC
Sanofi acquires Blueprint Medicines for $129 per share or $9.1B
PremiumThe Fly
Sanofi acquires Blueprint Medicines for $129 per share or $9.1B
6d ago
SNY
BPMC
Sanofi’s Promising Pipeline and Competitive Positioning Justify Buy Rating Despite Mixed Study Results
PremiumRatings
Sanofi’s Promising Pipeline and Competitive Positioning Justify Buy Rating Despite Mixed Study Results
8d ago
SNY
Regeneron, Sanofi: AERIFY-1 Phase 3 trial of itepekimab met primary endpoint
PremiumThe Fly
Regeneron, Sanofi: AERIFY-1 Phase 3 trial of itepekimab met primary endpoint
9d ago
SNY
REGN
Sanofi announces presentation of data on Beyfortus in RSV immunization
PremiumThe FlySanofi announces presentation of data on Beyfortus in RSV immunization
9d ago
SNY
Vigil Neuroscience to be acquired by Sanofi for $8.00 per share
Premium
The Fly
Vigil Neuroscience to be acquired by Sanofi for $8.00 per share
17d ago
SNY
VIGL
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
17d ago
SNY
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >